PRODUCT NEWS

ELITechGroup Announces Direct Sales and Customer Support in Canada

ELITechGroup Inc., recognized worldwide for proven performance and reliability of clinical laboratory diagnostic equipment and reagents, and recipient of SelectScience’s Clinical Company of the Year for 2019, announces that it will be managing sales, customer support, applications support, service and supply chain directly in Canada. For over 30 years, ELITechGroup Inc. has partnered with its Canadian distribution partner to offer Aerospray® Stainers, Cytocentrifuges, Sweat Test Systems, and Vapor Pressure Osmometer to customers all over Canada. “We are grateful for the strategic partnership we have maintained with Discovery Diagnostics, our exclusive Canadian Distribution Partner. Direct access to our end-users is a key strategic initiative that enables the company to better understand the needs of an ever changing laboratory environment. As ELITechGroup moves forward to provide direct sales and support in Canada, the company will continue to innovate in a way that provides the very best solutions for the end user,” says Bryce McEuen, Vice President, Biomedical Systems. For more information about ELITechGroup, visit their website at www.ELITechGroup.com. About ELITechGroup ELITechGroup is a privately held group of worldwide manufacturers and distributors of in vitro diagnostic equipment and reagents for clinical systems, microbiology, molecular diagnostics, hematology, and sweat test systems. Their mission is to improve patient care by empowering laboratories to do more in less time, with accuracy, to enable rapid and accurate course of treatment for patients. View Official Press Release>>

Latest news

NEWSROOM

Validation of our Amoebiasis kits published in Journal of Clinical Microbiology

ELITechGroup Microbiology is pleased to announce that a recent study published in the Journal of Clinical Microbiology (DOI: 10.1128/jcm.00179-25) confirms the strong performance of the serological assays ELI.H.A Amoeba and ELITex Bicolor Amoeba, designed for the diagnosis of Entamoeba histolytica for amoebiasis infections. This evaluation compared four commercial assays across…

ELITechGroup Announces Regulatory Approval of its Blood Borne Virus Panel in Japan

ELITechGroup’s blood-borne virus (BBV) panel received approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) The ELITe BBV panel was launched in 2022 and comprises three quantitative IVD assays targeting Human Immunodeficiency virus-1 (HIV-1), Human Hepatitis B Virus (HBV), and Human Hepatitis C Virus (HCV) Turin, June 13, 2024: ELITechGroup…

ELITechGroup achieves a new CE-IVDR Certification

ELITechGroup continues to expand its portfolio of IVDR-certified PCR assays to support European diagnostic laboratories The newly obtained IVDR certificate will expedite the transition to IVDR for quantitative Class C infectious diseases assays The company is fully committed to delivering its entire portfolio of nearly 60 molecular assays as IVDR…

Let us help you

For general inquiries, please use the links to the right. The Contact link leads to a brief online form, and the Support link offers general phone and email information. Someone will be in touch with you soon.